Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (107)	4/20/1999 6:57:00 AM
From: Mike McFarland	Respond to of 555

Well, who can say--but I am somewhat reassured by what you say. Of course it should be pointed out that Onyx actually rose to $8 yesterday, before declining in the last hour, on lightening volume. Maybe the MM walked it down for some reason. I have to say, I was tempted to sell up there near $10 when I had the chance last week, since my cost is around $6, but I really did think that cat was out of the bag on this one--and that going into ASCO meeting, folks would like to hold it, rather than give up their shares. If the thing continues to sag, I will be very confused. Of course, it should be pointed out, that based on McCamant freebie newsletter from his MSTL site, ONXX is a buy under $8--could that imply to some folks that Onyx is a sell over eight, that would be crazy talk. Here is the url to issue 363, the freebie I mentioned. bioinvest.com It is a little stale, for instance GMED was merged with MBIO. Several of the stocks I own are McCamant picks--very generous of him to have the freebie's on his site. If I make some money, I may even have to subscribe! Where his picks overlap with the biotech guys here on SI, there must be some very good ideas. Well, whatever happens today, I'll be sleeping through it. Last in the current set of graveyard shifts...then rejoining the real world for a few days starting tommorrow. Goodnite. -Mike